StockData
Adicet Bio, Inc. logo

Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$2.75−0.03 (-1.08%)

Close on Nov 16, 2026Market cap $25.74MP/E –Yield –

Adicet Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Adicet Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$84.53M. For fiscal 2025 it was -$95.25M. The highest annual figure on record is -$10.99M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$95.25M–
FY2024Dec 31, 2024-$92.38M–
FY2023Dec 31, 2023-$93.72M–
FY2022Dec 31, 2022-$44.77M–
FY2021Dec 31, 2021-$51.05M–
FY2020Dec 31, 2020-$41.55M–
FY2019Dec 31, 2019-$27.88M–
FY2018Dec 31, 2018-$18.18M–
FY2017Dec 31, 2017-$10.99M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$19.82M–
Q1 FY2026Mar 31, 2026-$21.49M–
Q4 FY2025Dec 31, 2025-$20.91M–
Q3 FY2025Sep 30, 2025-$22.31M–
Q2 FY2025Jun 30, 2025-$26.63M–
Q1 FY2025Mar 31, 2025-$25.40M–
Q4 FY2024Dec 31, 2024-$24.10M–
Q3 FY2024Sep 30, 2024-$22.01M–
Q2 FY2024Jun 30, 2024-$23.42M–
Q1 FY2024Mar 31, 2024-$22.85M–
Q4 FY2023Dec 31, 2023-$23.49M–
Q3 FY2023Sep 30, 2023-$21.24M–
Q2 FY2023Jun 30, 2023-$24.90M–
Q1 FY2023Mar 31, 2023-$24.09M-686.9%
Q4 FY2022Dec 31, 2022-$18.84M–
Q3 FY2022Sep 30, 2022-$15.33M–
Q2 FY2022Jun 30, 2022-$14.71M–
Q1 FY2022Mar 31, 2022$4.11M–
Q4 FY2021Dec 31, 2021-$13.44M–
Q3 FY2021Sep 30, 2021-$9.68M–
Q2 FY2021Jun 30, 2021-$12.78M–
Q1 FY2021Mar 31, 2021-$15.15M–
Q4 FY2020Dec 31, 2020-$13.35M–
Q3 FY2020Sep 30, 2020-$7.85M-240.1%
Q2 FY2020Jun 30, 2020-$12.01M–
Q1 FY2020Mar 31, 2020-$8.35M–
Q4 FY2019Dec 31, 2019-$7.26M-175.4%
Q3 FY2019Sep 30, 2019$5.60M–
Q2 FY2019Jun 30, 2019-$14.18M–
Q1 FY2019Mar 31, 2019-$12.05M–
Q4 FY2018Dec 31, 2018$9.63M–
Q3 FY2018Sep 30, 2018-$10.72M–
Q2 FY2018Jun 30, 2018-$9.78M–
Q1 FY2018Mar 31, 2018-$7.30M–
Q4 FY2017Dec 31, 2017-$4.99M–
Q3 FY2017Sep 30, 2017-$3.86M–
Q2 FY2017Jun 30, 2017-$1.85M–
Q1 FY2017Mar 31, 2017-$294.00K–

More Adicet Bio figures

See a number that looks wrong?